Beyond the hype: a comprehensive exploration of CBD’s biological impacts and mechanisms of action
Abstract Background: Cannabidiol (CBD) is the primary non-psychoactive component of cannabis. Consumption of CBD is increasing rapidly as it is…
Abstract Background: Cannabidiol (CBD) is the primary non-psychoactive component of cannabis. Consumption of CBD is increasing rapidly as it is…
Abstract Background/Objectives: Cannabigerol (CBG) is a non-psychoactive phytocannabinoid with significant therapeutic potential, showing emerging applications in drug delivery. This study…
Abstract Background/Objectives: Recent evidence supporting the medicinal use of cannabis has brought significant regulatory changes regarding its legal status, cultivation,…
Abstract After cannabidiol was extracted from the hemp biomass using supercritical CO2 extraction, the residual could be utilized as a…
Abstract Background/Objectives: Age-related macular degeneration (AMD) is the third leading cause of irreversible blindness in elderly individuals aged over 50…
Abstract Aging is associated with cognitive decline, and currently, there are no approved medications that can prevent these impairments. Recently,…
Abstract Background: The introduction of medical cannabis in Greece marks a shift in healthcare policy, yet patient attitudes remain underexplored.…
Abstract Quercetin (QUE) possesses various pharmacological properties; however, its low bioavailability and solubility hinder its beneficial effects. Enzymatic glycosylation has…
Abstract Visceral leishmaniasis (VL) is a neglected parasitic disease, and the first‐line treatments for VL include drugs that exhibit serious…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s13353-025-00970-8. Article type: Research Article Keywords: CBD, Hypothalamic neurons,…